206 related articles for article (PubMed ID: 32843902)
1. Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF
Zhan J; Zhang LH; Yu Q; Li CL; Chen Y; Wang WP; Ding H
Ther Adv Med Oncol; 2020; 12():1758835920942367. PubMed ID: 32843902
[TBL] [Abstract][Full Text] [Related]
2. Conventional Ultrasound, Immunohistochemical Factors and BRAF
Chen J; Li XL; Zhao CK; Wang D; Wang Q; Li MX; Wei Q; Ji G; Xu HX
Ultrasound Med Biol; 2018 Nov; 44(11):2296-2306. PubMed ID: 30100099
[TBL] [Abstract][Full Text] [Related]
3. Value of Combining Clinical Factors, Conventional Ultrasound, and Contrast-Enhanced Ultrasound Features in Preoperative Prediction of Central Lymph Node Metastases of Different Sized Papillary Thyroid Carcinomas.
Wang Y; Nie F; Wang G; Liu T; Dong T; Sun Y
Cancer Manag Res; 2021; 13():3403-3415. PubMed ID: 33907464
[TBL] [Abstract][Full Text] [Related]
4. Predicting factors of central lymph node metastasis and BRAF
Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF
World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769
[TBL] [Abstract][Full Text] [Related]
5. Integrating BRAF
Zhang Z; Zhang X; Yin Y; Zhao S; Wang K; Shang M; Chen B; Wu X
BMC Cancer; 2022 Apr; 22(1):461. PubMed ID: 35473554
[TBL] [Abstract][Full Text] [Related]
6. The synergic effect of BRAF
Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Relevance of the Ultrasonographic Features of Papillary Thyroid Carcinoma and Cervical Lymph Node Metastasis on Conventional and Contrast-Enhanced Ultrasonography.
Xue T; Liu C; Liu JJ; Hao YH; Shi YP; Zhang XX; Zhang YJ; Zhao YF; Liu LP
Front Oncol; 2021; 11():794399. PubMed ID: 35004319
[TBL] [Abstract][Full Text] [Related]
8. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy.
Zhan J; Diao X; Chen Y; Wang W; Ding H
Clin Hemorheol Microcirc; 2019; 72(1):61-73. PubMed ID: 30452407
[TBL] [Abstract][Full Text] [Related]
9. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.
Howell GM; Nikiforova MN; Carty SE; Armstrong MJ; Hodak SP; Stang MT; McCoy KL; Nikiforov YE; Yip L
Ann Surg Oncol; 2013 Jan; 20(1):47-52. PubMed ID: 22941165
[TBL] [Abstract][Full Text] [Related]
10. Quantitative parameters of contrast-enhanced ultrasound effectively promote the prediction of cervical lymph node metastasis in papillary thyroid carcinoma.
Su B; Li L; Liu Y; Liu H; Zhan J; Chai Q; Fang L; Wang L; Chen L
Drug Discov Ther; 2024 Mar; 18(1):44-53. PubMed ID: 38355122
[TBL] [Abstract][Full Text] [Related]
11. A prediction model incorporating the BRAF
Liu S; Liu C; Zhao L; Wang K; Li S; Tian Y; Jiao B; Gui Z; Yu T; Zhang L
Eur J Surg Oncol; 2021 Nov; 47(11):2774-2780. PubMed ID: 34483032
[TBL] [Abstract][Full Text] [Related]
12. Application of decision tree algorithms to predict central lymph node metastasis in well-differentiated papillary thyroid carcinoma based on multimodal ultrasound parameters: a retrospective study.
Wan F; He W; Zhang W; Zhang H; Zhang Y; Guang Y
Quant Imaging Med Surg; 2023 Apr; 13(4):2081-2097. PubMed ID: 37064365
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of Ultrasound Imaging Characteristics and a BRAF V600E Nomogram for Central Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
Zhu D; Wu X; Zhang L; Chen Z
Altern Ther Health Med; 2023 Nov; 29(8):139-143. PubMed ID: 37632946
[TBL] [Abstract][Full Text] [Related]
14. Homogeneity Parameter in Contrast-Enhanced Ultrasound Imaging Improves the Classification of Abnormal Cervical Lymph Node after Thyroidectomy in Patients with Papillary Thyroid Carcinoma.
Zhan J; Diao XH; Chen Y; Wang WP; Ding H
Biomed Res Int; 2019; 2019():9296010. PubMed ID: 31886269
[TBL] [Abstract][Full Text] [Related]
15. Clinical Study of Ultrasonographic Risk Factors for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Guang Y; He W; Zhang W; Zhang H; Zhang Y; Wan F
Front Endocrinol (Lausanne); 2021; 12():791970. PubMed ID: 34917039
[TBL] [Abstract][Full Text] [Related]
16. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1.
Jianming L; Jibin L; Linxue Q
Eur J Radiol; 2020 Feb; 123():108801. PubMed ID: 31918249
[TBL] [Abstract][Full Text] [Related]
17. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).
Gao X; Luo W; He L; Cheng J; Yang L
Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002
[TBL] [Abstract][Full Text] [Related]
18. Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma.
Park AY; Son EJ; Kim JA; Youk JH; Park YJ; Park CS; Chang HS
PLoS One; 2014; 9(10):e110868. PubMed ID: 25337709
[TBL] [Abstract][Full Text] [Related]
19. Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with
Li GY; Tan HL; Chen P; Hu HY; Liu M; Ou-Yang DJ; Khushbu RA; Pun D; Li JD; Zhang ZP; Yang Q; Huang P; Chang S
Cancer Manag Res; 2020; 12():3371-3378. PubMed ID: 32494201
[TBL] [Abstract][Full Text] [Related]
20. Value of Multimodal Ultrasound Combined with BRAF Gene in Evaluating Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma.
Xue J; Qu N; Liu H; Bi M; Cao X
Ultrasound Med Biol; 2024 Aug; 50(8):1183-1187. PubMed ID: 38704301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
